Search

Your search keyword '"Hoft, Daniel"' showing total 589 results

Search Constraints

Start Over You searched for: Author "Hoft, Daniel" Remove constraint Author: "Hoft, Daniel"
589 results on '"Hoft, Daniel"'

Search Results

1. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

4. Risk of COVID-19 after natural infection or vaccination

6. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

8. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

10. Review of Current Tuberculosis Human Infection Studies for Use in Accelerating Tuberculosis Vaccine Development: A Meeting Report.

11. Tristetraprolin mediates immune evasion of mycobacterial infection in macrophages.

12. Human challenge trial workshop: Focus on quality requirements for challenge agents, Langen, Germany, October 22, 2019

14. Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy

17. Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo

18. 2395. An Interim Report of the Safety, Reactogenicity, and Immunogenicity of a Self-amplifying mRNA (samRNA) COVID-19 Vaccine GRT-R910 as a Booster in Healthy Adults

19. Risk of COVID-19 after natural infection or vaccination

21. Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

23. Homodimeric Granzyme A Opsonizes Mycobacterium tuberculosis and Inhibits Its Intracellular Growth in Human Monocytes via Toll-Like Receptor 4 and CD14

24. Identification of immunodominant T cell epitopes induced by natural Zika virus infection

26. Thresholds versus Anomaly Detection for Surveillance of Pneumonia and Influenza Mortality

27. A New Recombinant Bacille Calmette-Guérin Vaccine Safely Induces Significantly Enhanced Tuberculosis-Specific Immunity in Human Volunteers

30. Homodimeric Granzyme A Opsonizes Mycobacterium tuberculosis and Inhibits Its Intracellular Growth in Human Monocytes via Toll-Like Receptor 4 and CD14.

31. Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial.

48. Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies

49. A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults

50. The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies

Catalog

Books, media, physical & digital resources